BackUltimovacs ASA Overview

Ultimovacs ASA Total Current Liabilities

Track Ultimovacs ASA's total current liabilities ($9.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$9.55M
↓ 40.53% YoYΔ $-6.51M vs prior year quarter

Peer trimmed avg / median

Loading

Ultimovacs ASA Total Current Liabilities History

Loading

Ultimovacs ASA vs. peers: Total Current Liabilities Comparison

Loading

Ultimovacs ASA Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ultimovacs ASA (ULTI.OL) FAQ

Ultimovacs ASA (ULTI.OL) currently reports a total current liabilities of $9.6M as of September 2026. That compares with $16M in the prior-year period — down 40.5% year over year. Use the charts on this page to explore Ultimovacs ASA's total current liabilities history and peer comparisons.

Ultimovacs ASA's total current liabilities decreased from $16M to $9.6M — a 40.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ultimovacs ASA reported $9.6M in total current liabilities as of September 2026. That compares with $16M in the prior-year period — down 40.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $9.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ultimovacs ASA, and consider following ULTI.OL for alerts when major investors trade the stock.

Ultimovacs ASA is classified in the Healthcare sector. On total current liabilities, it currently shows $9.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ULTI.OL with unrelated industries.